Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Characteristics of Familial CLL Evaluated in the CLL Research Consortium Cohort

Jennifer R Brown, MD, PhD, Laura Rassenti, PhD, Donna Neuberg, ScD, Andrew Greaves, John C. Byrd, Michael R Grever, John G. Gribben, MD, DSc, Neil E. Kay, Michael Keating, MB, BS, Kanti R. Rai, MD, William G. Wierda, Thomas J Kipps

Blood (2008) 112 (11): 3125.

https://doi.org/10.1182/blood.V112.11.3125.3125

Published: 2008

Journal Articles

Standardizing Co-Culture Conditions Between Chronic Lymphocytic Leukemia Cells and Marrow Stromal Cells: Towards a Reliable and Reproducible System to Assess Cell Adhesion-Mediated Drug Resistance

Antonina Kurtova, MS, Maite P. Quiroga, BS, William G. Wierda, M.D., Ph.D, Michael Keating, MB, BS, Jan A. Burger, MD, PhD

Blood (2008) 112 (11): 3149.

https://doi.org/10.1182/blood.V112.11.3149.3149

Published: 2008

Journal Articles

Inhibition of BCR Signaling Using the SYK Inhibitor R406 Antagonizes Migratory and Pro-Survival Responses in CLL Cells.

Maite P. Quiroga, BS, Antonina Kurtova, MS, William Wierda, MD, PhD, Michael Keating, MB, BS, Jan A. Burger, MD, PhD

Blood (2008) 112 (11): 2064.

https://doi.org/10.1182/blood.V112.11.2064.2064

Published: 2008

Journal Articles

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Fabio P.S. Santos, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Charles A. Koller, MD, Miloslav Beran, MD, PhD, Gautam Borthakur, MD, Carlos Bueso-Ramos, MD, PhD, Michael Keating, MB, BS, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD

Blood (2008) 112 (11): 925.

https://doi.org/10.1182/blood.V112.11.925.925

Published: 2008

Journal Articles

Treatment Effect of First Line Rituximab, Fludarabine and Cyclosphosphamide in a Chronic Lymphocytic Leukemia Patient Cohort: An Evaluation of Prognostic Factors, Estimated Life Expectancy and Economic Outcomes

Emma Carr, PhD, Susan Lerner, M.S., RHAI, Rick Aultman, MSc, Ute Weisgerber-Kriegl, PhD, Michael Keating, MB, BS

Blood (2008) 112 (11): 2396.

https://doi.org/10.1182/blood.V112.11.2396.2396

Published: 2008

Journal Articles

All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As 2 O 3 ) Combination Therapy Induces High Rates of Durable Molecular Remission in Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Apostolia-Maria Tsimberidou, MD, PhD, Hagop Kantarjian, MD, Susan O’Brien, MD, Guillermo Garcia-Manero, MD, Charles Koller, MD, Daniel Jones, MD, Sherry Pierce, RN, Mark Brandt, BA, Michael Keating, MB, BS, Estey Estey, MD

Blood (2007) 110 (11): 1834.

https://doi.org/10.1182/blood.V110.11.1834.1834

Published: 2007

Journal Articles

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Marina Motta, MD, William Wierda, MD, PhD, Susan O’Brien, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Michelle Detry, PhD, Susan Lerner, MS, Hagop Kantarjian, MD, Michael Keating, MB, BS

Blood (2005) 106 (11): 720.

https://doi.org/10.1182/blood.V106.11.720.720

Published: 2005

NARROW

Characteristics of Familial CLL Evaluated in the CLL Research Consortium Cohort

Standardizing Co-Culture Conditions Between Chronic Lymphocytic Leukemia Cells and Marrow Stromal Cells: Towards a Reliable and Reproducible System to Assess Cell Adhesion-Mediated Drug Resistance

Inhibition of BCR Signaling Using the SYK Inhibitor R406 Antagonizes Migratory and Pro-Survival Responses in CLL Cells.

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Treatment Effect of First Line Rituximab, Fludarabine and Cyclosphosphamide in a Chronic Lymphocytic Leukemia Patient Cohort: An Evaluation of Prognostic Factors, Estimated Life Expectancy and Economic Outcomes

All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As 2 O 3 ) Combination Therapy Induces High Rates of Durable Molecular Remission in Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Characteristics of Familial CLL Evaluated in the CLL Research Consortium Cohort

Standardizing Co-Culture Conditions Between Chronic Lymphocytic Leukemia Cells and Marrow Stromal Cells: Towards a Reliable and Reproducible System to Assess Cell Adhesion-Mediated Drug Resistance

Inhibition of BCR Signaling Using the SYK Inhibitor R406 Antagonizes Migratory and Pro-Survival Responses in CLL Cells.

Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.

Treatment Effect of First Line Rituximab, Fludarabine and Cyclosphosphamide in a Chronic Lymphocytic Leukemia Patient Cohort: An Evaluation of Prognostic Factors, Estimated Life Expectancy and Economic Outcomes

All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As 2 O 3 ) Combination Therapy Induces High Rates of Durable Molecular Remission in Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only